Algo version: 0.98b
Vitrolife AB (publ) is listed at the STO Exchange
Vitrolife AB (publ) [VITR.ST]
STO Sector: Healthcare Industry:Medical Devices

Is Vitrolife AB (publ) stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, Vitrolife AB (publ) pays dividends. Last time was Friday 3rd of May 2024 where the investors holding the stock on Friday 26th of April 2024 were paid SEK1 per share. Over the last 16 times between 2009 and 2024, Vitrolife AB (publ) has paid SEK19.25 with an average of SEK1.2 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Vitrolife AB (publ) 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was SEK157.50, you would have made a profit of SEK95.50 per share or 60.63%

Yes, the average daily trading liquidity for Vitrolife AB (publ) is SEK94 610 thousand. You should therefore be able to get in and out of your positions relatively fast.

Vitrolife AB (publ) has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.40, the company's ability to pay off the debt is normal. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Vitrolife AB (publ) to be high [0.7 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.